The panel-targeted sequencing results of tumor specimens revealed high incidences of oncogenic PIK3CA and DNMT3A mutations in patients aged ≥65 years, which highlighted the impact of age-dependent genomic alterations on CRC tumorigenesis. Here, DNMT3A is linked to neoplasm.